CAS: 20028-53-9; 2-Amino-5-Chlorobenzaldehyde

上下游产品

CAS号37585-25-4 2-氨基-5-氯苯甲醇 | CAS号6628-86-0 5-氯-2-硝基苯甲醛 | CAS号106-47-8 对氯苯胺 | CAS号68-12-2 N,N-二甲基甲酰胺 | CAS号587-04-2 3-氯苯甲醛 | CAS号635-21-2 2-氨基-5-氯苯甲酸 | CAS号719-59-5 2-氨基-5-氯二苯甲酮 | CAS号700-78-7 6-氯喹唑啉 | CAS号114858-39-8 6-氯-2-甲基喹啉-3-羧酸乙酯 | CAS号1204390-45-3 6-chloroquinazo... | CAS号109581-98-8 10-chloro-(20RS... | CAS号1207-96-1 Acridine, 2-chloro | CAS号85274-64-2 6-氯-3-苯基-2-喹啉醇 | CAS号881668-94-6 6-chloro-2-meth... | CAS号92525-74-1 6-氯喹啉-2,3-二羧酸二乙酯 | CAS号58058-53-0 6-chloro-2-phen...

2-氨基-5-氯苯甲醇置于manganese(Iv) Oxide体系中,用 二氯甲烷 用作溶剂,化学反应 24.0H,反应生成2-氨基-5-氯苯甲醛
参考文献:手性布朗斯台德酸催化的异喹啉萘并吡啶类化合物的不对称合成
标题:手性布朗斯台德酸催化的异喹啉萘并吡啶类化合物的不对称合成
摘要:已开发出一种催化不对称方法,用于合成手性异喹啉基萘并吡啶.手性二磺酰亚胺催化2-甲基-3-醛氮杂氮杂烯与1,2,3,4-四氢异喹啉之间的氧化还原环化,从而以高至高收率(高达91%)和高达92:8 Er释放出一系列的异喹啉萘并吡啶.
Doi:10.1039/c7Ob01527E

专利信息

专利号:US-4894456-A
优先权日:1987-03-31
标题 :Synthesis of camptothecin and analogs thereof
发明人：WALL MONROE E; WANI MANSUKH C; NICHOLAS ALLAN W; MANIKUMAR GOVINDARAJAN
权利人:RES TRIANGLE INST
摘要:A method for synthesizing camptothecin and camptothecin analogs using a novel hydroxyl-containing tricyclic intermediate and the camptothecin analogs produced by the process. The camptothecin analogs are effective inhibitors of topoisomerase I and show anti-leukemic and anti-tumor activity.

专利号:US-11040977-B2
优先权日:2013-12-05
标题 :Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crytalline forms thereof
发明人：ROTHENHAEUSLER BENNO; TRUSSARDI RENE; HOFFMANN-EMERY FABIENNE; SCHWITTER URS; ADAM JEAN-MICHEL; GRASSMANN OLAF; HARTUNG THOMAS; RAN FREDERIC; DIODONE RALPH; PFLEGER CHRISTOPHE; BARTELS BJORN
权利人:HOFFMANN LA ROCHE
摘要:The invention provides processes to manufacture substituted 1-[4-(Pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes. Also disclosed are compounds useful as intermediates in the methods of the invention.

专利号:US-4981968-A
优先权日:1987-03-31
标题:Synthesis of camptothecin and analogs thereof
发明人：WALL MONROE E; WANI MANSUKH C; NICHOLAS ALLAN W; MANIKUMAR GOVINDARAJAN
权利人:RES TRIANGLE INST
摘要:A method for synthesizing camptothecin and camptothecin analogs using a novel hydroxyl-containing tricyclic intermediate and the camptothecin analogs produced by the process. The camptothecin analogs are effective inhibitors of topoisomerase I and show anti-leukemic and anti-tumor activity.

专利号:US-2023295613-A1
优先权日:2020-02-14
标 题:Long chain carbon and cyclic amino acids substrates for genetic code reprogramming
发明人：JEWETT MICHAEL C; LEE JOONGOO; MOORE JEFFREY S; SCHWARZ KEVIN J
权利人:UNIV NORTHWESTERN; UNIV ILLINOIS
摘要:Abstract: Disclosed are methods, systems, components, and compositions for synthesis of sequence defined polymers. The methods, systems, components, and compositions may be utilized for incorporating novel substrates that include non-standard amino acid monomers and non-amino acid monomers into sequence defined polymers. As disclosed herein, the novel substrates may be utilized for acylation of tRNA via flexizyme catalyzed reactions. The tRNAs thus acylated with the novel substrates may be utilized in synthesis platforms for incorporating the novel substrates into a sequence defined polymer.

专利号:US-2024002405-A1
优先权日:2022-06-01
标题 :Antimicrobial compounds, synthesis methods, and uses thereof
发明人：VERMA RAJNI; DONAVALLI KRISHNA MOHAN; ZAID GENE H
权利人:ANKH LIFE SCIENCES LTD
摘要:Fused tricyclic compounds and novel methods of synthesizing, using, and/or administering the same. Methods of inhibiting microbial activity and/or treating a microbial infection with fused tricyclic compounds, bicyclic compounds, and other polycyclic compounds. The treatment of subjects suffering from a microbial infection comprises the step of administering to the subject one or more fused tricyclic compounds, bicyclic compounds, and other polycyclic compounds or a composition comprising one or more fused tricyclic compounds, bicyclic compounds, and other polycyclic compounds.

专利号:US-2019194210-A1
优先权日:2013-12-05
标 题 :Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulene and crytalline forms thereof